NCT01613378View on ClinicalTrials.gov

A Non-Interventional Study in Rheumatoid Arthritis Patients Treated With Tocilizumab (RoActemra/Actemra)

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Rheumatoid Arthritis
Interventions
OTHER

No intervention

No intervention administered in this study

Trial Locations (32)

T5M 0H4

Edmonton

V1Y 3G8

Kelowna

V9R 3G9

Nanaimo

V2A 3G8

Penticton

V5Z 1M9

Vancouver

V8P 5P6

Victoria

A1A 5E8

St. John's

A1C 5B8

St. John's

B0J 2C0

Lunenburg

B1S 3N1

Sydney

L6T 3J1

Brampton

L7L 0B7

Burlington

L8N 2B6

Hamilton

L6B 1A1

Markham

L5M 2V8

Mississauga

L3Y 3R7

Newmarket

L2N 7E4

St. Catharines

M4S 2B8

Toronto

M5G 1X5

Toronto

N8X 5A6

Windsor

H7G 2E6

Laval

H1T 2M4

Montreal

H2L 1S6

Montreal

H2L 4M1

Montreal

H3T 1Y6

Montreal

H9R 3J1

Pointe-Claire

G1V 3M7

Québec

G5L 8W1

Rimouski

J7P 4J2

Saint-Eustache

J1H 5N4

Sherbrooke

G8Z 1Y2

Trois-Rivières

S7K 0H6

Saskatoon

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01613378 - A Non-Interventional Study in Rheumatoid Arthritis Patients Treated With Tocilizumab (RoActemra/Actemra) | Biotech Hunter | Biotech Hunter